These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 5529419

  • 21. [The thyroid dose in radioiodine uptake. Critical analysis of estimation methods].
    Buraggi GL.
    Radiobiol Radioter Fis Med; 1966; 21(1):41-54. PubMed ID: 5934741
    [No Abstract] [Full Text] [Related]

  • 22. [Ambulatory treatment of hyperthyroidism with radioactive 131-I].
    Gasiorowski W, Chomicki O, Górowski T.
    Pol Tyg Lek; 1971 Sep 20; 26(38):1457-9. PubMed ID: 5112755
    [No Abstract] [Full Text] [Related]

  • 23. [Dynamics of autoantibodies level in patients with thyroid diseases treated with I-131 and medical agents].
    Islambekov RK, Aulov DM, Nikolaev AI, Platonova LB, Aripov D, Tremasova GIa.
    Probl Endokrinol (Mosk); 1970 Sep 20; 16(2):32-5. PubMed ID: 5441667
    [No Abstract] [Full Text] [Related]

  • 24. [Calculation of the total dose of therapeutic irradiation delivered to the thyroid gland by radioiodine-131].
    Peyrin JO, Berger M.
    Rev Lyon Med; 1966 Jan 15; 15(1):27-62. PubMed ID: 5903476
    [No Abstract] [Full Text] [Related]

  • 25. I-131 treatment for toxic diffuse goiter. Analysis of 1056 cured cases.
    Yang HF.
    Nagoya J Med Sci; 1972 Mar 15; 34(4):283-96. PubMed ID: 4665962
    [No Abstract] [Full Text] [Related]

  • 26. Iodine-125 in hyperthyroidism.
    Br Med J; 1972 Jan 15; 1(5793):126. PubMed ID: 5007831
    [No Abstract] [Full Text] [Related]

  • 27. [Late results of fractionates radioiodine therapy. Controlled studies in hyperthreoses following 2-11 years].
    Reinwein D, Miss H, Horster FA, Berger H, Klein E, Oberdisse K.
    Dtsch Med Wochenschr; 1968 Dec 13; 93(50):2416-20. PubMed ID: 4177324
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of thyrotoxicosis with 125-I and 131-I.
    Lewitus Z, Lubin E, Rechnic J, Ben-Porath M, Feige Y.
    Semin Nucl Med; 1971 Oct 13; 1(4):411-21. PubMed ID: 4107459
    [No Abstract] [Full Text] [Related]

  • 36. [Physical and biological presuppositions for an improvement in the technic of metabolic radiotherapy of thyrotoxicoses].
    Buraggi GL.
    Radiobiol Radioter Fis Med; 1966 Oct 13; 21(2):86-98. PubMed ID: 5942630
    [No Abstract] [Full Text] [Related]

  • 37. [Experiences with the determination of thyroid antibodies].
    Sievers P, Leverenz S, Schwartz KD.
    Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:101-3. PubMed ID: 5402562
    [No Abstract] [Full Text] [Related]

  • 38. Thyroid antibodies after 131-I treatment for hyperthyroidism.
    Einhorn J, Fagraeus A, Jonsson J.
    J Clin Endocrinol Metab; 1965 Sep 01; 25(9):1218-24. PubMed ID: 5318909
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Diagnosis and therapy with radioactive isotopes].
    Gehrmann G.
    Lebensversicher Med; 1966 Jul 01; 18(3):108-12. PubMed ID: 4383341
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.